IL4 and infection: Intriguingly, after ex vivo infection of interleukin-4 (IL-4)/IL-13-treated skin, we observed infected cells supporting that Th2 responses already enabled the virus to overcome the protective skin barrier and gain access to its receptors to initiate infection.